• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: cell

  • Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival
    • in Oncology
    • — 28 Jul, 2009

    Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

    Treatment of advanced pancreatic islet cell tumors with sunitinib has doubled progression-free survival in patients whose options have been very limited up to now, according to French researchers reporting their phase III randomized study findings at the World Congress on …

    Read more
    Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer
    • in General Medicine
    • — 21 Mar, 2008

    Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

    Giorgio Scagliotti
    Giorgio Scagliotti
    Robert Pirker
    Robert Pirker

    GIORGIO SCAGLIOTTI, University of Turin
    ROBERT PIRKER, Medical University of Vienna
    A heated debate took place at the European Congress on Lung Cancer in Turin between Robert Pirker who is in favor of offering
    …
    Read more
  • Bevacizumab: New Standard for Non-Small Cell Lung Cancer?
    • in Oncology
    • — 16 Mar, 2008

    Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

    Christian Manegold
    Christian Manegold
    Nick Thatcher
    Nick Thatcher
    Christian Manegold, Heidelberg University Medical Center, Manheim
    Nick Thatcher, Christie Hospital, Manchester

    Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question

    …
    Read more
    Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
    • in News · Oncology
    • — 26 Feb, 2008

    Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

    Martin Dreyling
    Martin Dreyling

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    MARTIN DREYLING, University Hospital Grosshaden, Munich
    Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He
    …
    Read more
    • in Oncology
    • — 11 Dec, 2007

    Live Report from ASH:
    Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?

    Christian Geisler
    Christian Geisler

    CHRISTIAN GEISLER, Rigshospitalet, Copenhagen
    Mantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek Thorne got the details on the study – which featured an intensive immunochemotherapy
    …
    Read more
    No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia
    • in Public Health
    • — 9 Dec, 2007

    No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

    Zakari Aliyu
    Zakari Aliyu

    REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
    ZAKARI ALIYU, Howard University, Washington DC
    Nigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with
    …
    Read more
  • Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
    • in Oncology
    • — 16 Nov, 2007

    Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

    Jean-Yves Douillard
    Jean-Yves Douillard
    Gordon McVie
    Gordon McVie

    REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    The vinca alkaloid vinflunine and
    …
    Read more
    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer
    • in Oncology
    • — 16 Oct, 2007

    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

    Jose Baselga
    Jose Baselga
    Gordon McVie
    Gordon McVie

    REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    Neoadjuvant trastuzumab for patients with HER2-positive
    …
    Read more
  • Audio Journal of Medicine – July 20th
    • in General Medicine
    • — 20 Jul, 2006

    Audio Journal of Medicine – July 20th

    Jean Scott and Peter Illingworth
    Jean Scott and Peter Illingworth
    Richard Anderson
    Richard Anderson
    Anna Pia Ferraretti
    Anna Pia Ferraretti

    More Boys from IVF compared to ICSI

    REFERENCE: Abstract O-41
    Jean Scott, IVF Australia, Hunters Hill, New South Wales; Peter Illingworth, Medical Director of IVF Australia
    In vitro fertilisation results
    …
    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: cell

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.